Woojin B&G Signs Exclusive Domestic Distribution Agreement for Pet Probiotic 'Meongmeong Jeongjang' with DC Pharm

[Asia Economy Reporter Yoo Hyun-seok] Woojin B&G announced on the 7th that it has signed an exclusive domestic distribution contract with DC Pharm for the pet-exclusive probiotic product 'Meongmeong Jeongjang.'

Meongmeong Jeongjang is the first product in Korea to use probiotic strains derived from the intestines of dogs as the main ingredient. Domestic clinical trials have shown that it greatly helps restore the diversity of the gut microbiota in dogs and enhances the robustness of the microbiome and immunity.

Additionally, it has a high survival ability against gastric juice and bile acids, so it is expected to have preventive effects against viral diarrhea such as canine parvovirus enteritis and coronavirus enteritis, as well as bacterial diarrhea, which can occur due to weakened immunity. Taking Meongmeong Jeongjang in advance to boost immunity is expected to help prevent various diseases by restoring intestinal health.

A marketing official from Woojin B&G said, "Along with the selection of the exclusive domestic distributor, the packaging of Meongmeong Jeongjang has been changed from the existing brown to a fresh white design, and full-scale marketing has begun," adding, "The synergy effect of Woojin B&G's technological capabilities and DC Pharm's distribution capacity will strengthen our position in the pet market."

This content was produced with the assistance of AI translation services.